ميرزا جواد

Led end-to-end revenue and expense reporting for Tripack
Films' manufacturing units, supporting over PKR 10 billion in
annual revenue, ensuring accurate, timely reporting and
contributing to 15% YoY margin predictability.

Delivered actionable financial analysis and planning for the
manufacturing leadership team, enabling data-driven
decisions that resulted in PKR 150 million+ in operational cost
optimizations over 3 years.

Drove cost-efficiency initiatives across energy, variable
manufacturing cost (VMC), and throughput, leading to a
cumulative savings of PKR 200 million, including a 12%
improvement in energy utilization.

Designed and implemented a real-time cost visibility
framework from the ground up, enabling plant operations
teams to monitor key cost drivers instantly and take proactive
actions pre-closing, significantly reducing reaction lag and
improving monthly cost control accuracy.

Identified supply chain risks with direct cost implications,
designing mitigation strategies that reduced financial
exposure from stockouts and expedited freight, safeguarding
P&L stability, and protecting gross margins during volatile
periods.

Chaired S&OP meetings with Sales Leadership, translating
demand volatility into financial forecasts and supply
strategies, leading to 15% improvement in forecast accuracy
and improved working capital efficiency, especially in highvariance SKUs.

Led annual budgeting for demand and supply planning,
integrating financial models with operations data to support
the strategic allocation of inventory investments, contributing
to optimized inventory-to-revenue ratios and reduced
obsolescence risk.

Consolidated and analyzed large cross-functional data sets
(commercial forecasts, production capacity, logistics lead
times), delivering actionable financial insights that supported
scenario planning and improved budget agility across supply
and demand cycles.

Introduced demand volatility buffers and dynamic allocation
tools, enhancing service levels while reducing excess
inventory, resulting in a 20% reduction in carrying costs and
positively impacting inventory holding lines on the P&L .

Developed and maintained rolling forecasts for inventory, purchase
plans, NPD phasing, and cash flow—ensuring tight alignment
between operational planning and liquidity management, directly
supporting P&L visibility and working capital optimization.

Led Capex and Opex budgeting cycles, tracking utilization through
automated Power BI dashboards, enabling real-time monitoring of
spend vs. plan and ensuring financial discipline aligned with strategic
investment priorities.

Prepared forward-looking financial projections and variance analyses
to support both internal and external audit readiness, strengthening
compliance and improving transparency across inventory,
procurement, and cash flow statements.

Analysed sales trends and distributor stock against sales plans during
a period of revenue growth from PKR 42.7billion (FY2015/16) to
PKR 50billion (FY2017/18), enabling accurate demand planning and
tighter stock level control across 100+ SKUs.

Formulated MRP/MPS plans with calibrated safety stock levels to align
with increased production activity and raw material lead times,
supporting consistent supply during years of rising operating profit
(e.g.,
+16% in FY2016/17).

Developed interactive inventory dashboards to monitor slow-moving,
at-risk, and near-expiry SKUs—supporting timely liquidation actions
and reduction in obsolete inventory exposure across multiple business
segments.

Led coordination between production, quality, warehouse, and
logistics teams to ensure product availability aligned with supply
plans, supporting efficient execution during periods of increased
operational scale (e.g., PKR 4.6billion operating profit in FY2017/18).

-Led the full lifecycle finance workstream—including feasibility,
valuation, acquisition modelling, budget integration, and system
rollout—for:

-Acquisition of Wyeth Pakistan’s Karachi manufacturing at a
final bid of PKR 1.91billion.

-Amalgamation of Cirin Pharmaceuticals (Pvt) Limited into ICI
Pakistan completed at PKR 1.1billion valuation.

Delivered timely financial insights and KPI dashboards to top
management, including variance analysis, profitability statements
with commentary, and quarterly performance reviews against budget
targets.